ATE321887T1 - Verfahren zur identifizierung von modulatoren des cholesterinrückwärtstransportes - Google Patents

Verfahren zur identifizierung von modulatoren des cholesterinrückwärtstransportes

Info

Publication number
ATE321887T1
ATE321887T1 AT02701394T AT02701394T ATE321887T1 AT E321887 T1 ATE321887 T1 AT E321887T1 AT 02701394 T AT02701394 T AT 02701394T AT 02701394 T AT02701394 T AT 02701394T AT E321887 T1 ATE321887 T1 AT E321887T1
Authority
AT
Austria
Prior art keywords
methods
reverse transport
identifying modulators
compounds capable
cholesterol reverse
Prior art date
Application number
AT02701394T
Other languages
English (en)
Inventor
Bart Staels
Original Assignee
Genfit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genfit filed Critical Genfit
Application granted granted Critical
Publication of ATE321887T1 publication Critical patent/ATE321887T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT02701394T 2001-02-05 2002-02-04 Verfahren zur identifizierung von modulatoren des cholesterinrückwärtstransportes ATE321887T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0101486A FR2820435B1 (fr) 2001-02-05 2001-02-05 Procedes d'identification de composes modulant le transport inverse du cholesterol

Publications (1)

Publication Number Publication Date
ATE321887T1 true ATE321887T1 (de) 2006-04-15

Family

ID=8859595

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02701394T ATE321887T1 (de) 2001-02-05 2002-02-04 Verfahren zur identifizierung von modulatoren des cholesterinrückwärtstransportes

Country Status (14)

Country Link
US (1) US20040115666A1 (de)
EP (1) EP1358354B1 (de)
JP (1) JP2004537272A (de)
KR (1) KR20030074740A (de)
CN (1) CN1568374A (de)
AT (1) ATE321887T1 (de)
AU (1) AU2002234729B2 (de)
CA (1) CA2437434A1 (de)
DE (1) DE60210253T2 (de)
DK (1) DK1358354T3 (de)
ES (1) ES2260413T3 (de)
FR (1) FR2820435B1 (de)
IL (1) IL156218A0 (de)
WO (1) WO2002063038A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050159362A1 (en) * 2003-04-22 2005-07-21 Sircar Jagadish C. Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
FR2864105B1 (fr) * 2003-12-23 2008-02-01 Genfit S A Procede pour identifier des composes modulant le transport inverse du cholesterol
UY28953A1 (es) * 2004-06-09 2006-01-31 Avanir Pharmaceuticals Derivados heterocíclicos para el tratamiento de hiperlipidemia y enfermedades relacionadas
EP1753733A1 (de) * 2004-06-09 2007-02-21 Avanir Pharmaceuticals Kleine moleküle zur behandlung von hypercholesterinämie und verwandten erkrankungen
KR20070029198A (ko) * 2004-06-09 2007-03-13 아바니르 파마슈티컬스 고콜레스테롤혈증의 치료를 위한 역 콜레스테롤 수송의매개제
KR100784859B1 (ko) * 2005-01-14 2007-12-14 한국과학기술연구원 형광편광도를 이용한 파네소이드 ｘ 수용체-리간드복합체의 상호작용 분석방법 및 결합 저해물질 검색방법
WO2007055873A2 (en) * 2005-11-04 2007-05-18 Avanir Pharmaceuticals Process for the manufacture of peptide facilitators of reverse cholesterol transport

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721096A (en) * 1991-01-24 1998-02-24 Children's Medical Center Corporation Methods of screening for compounds with ability to alter apolipoprotein AI gene expression
DE19709125A1 (de) * 1997-03-06 1998-09-10 Bayer Ag Substituierte Chinoline
JP2000109455A (ja) * 1998-08-06 2000-04-18 Shionogi & Co Ltd アポリポタンパク質ａｉ遺伝子発現亢進作用を有する化合物
US6465258B1 (en) * 1999-01-07 2002-10-15 Tularik, Inc. FXR receptor-mediated modulation cholesterol metabolism
AU780658B2 (en) * 1999-03-26 2005-04-07 City Of Hope Method of affecting cholesterol catabolism using nuclear bile acid receptor
US20020132223A1 (en) * 1999-03-26 2002-09-19 City Of Hope Methods for modulating activity of the FXR nuclear receptor

Also Published As

Publication number Publication date
FR2820435B1 (fr) 2004-02-27
DK1358354T3 (da) 2006-07-31
DE60210253D1 (de) 2006-05-18
FR2820435A1 (fr) 2002-08-09
CA2437434A1 (fr) 2002-08-15
IL156218A0 (en) 2003-12-23
DE60210253T2 (de) 2007-03-15
CN1568374A (zh) 2005-01-19
JP2004537272A (ja) 2004-12-16
AU2002234729B2 (en) 2007-05-31
EP1358354A1 (de) 2003-11-05
ES2260413T3 (es) 2006-11-01
KR20030074740A (ko) 2003-09-19
EP1358354B1 (de) 2006-03-29
WO2002063038A1 (fr) 2002-08-15
US20040115666A1 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
DE602005013670D1 (de) Zusammensetzungen und verfahren zur quantifizierung von serumglykoproteinen
ATE439592T1 (de) Proteingerüste für antikörper-nachahmer und andere bindende proteine
NO20025402D0 (no) Modifiserte ES-celler og ES-spesifikt gen
ATE237133T1 (de) Assays zur bestimmung von proteinfragmenten in biologischen medien
ATE498676T1 (de) Produkte auf basis von ionischen flüssigkeiten und verfahren zu deren verwendung
AU4185001A (en) Protein scaffolds for antibody mimics and other binding proteins
ATE421991T1 (de) Stammzellen und verfahren zu deren trennung
ATE274921T1 (de) Verfahren zur selektion von fxr- rezeptormodulatoren
DE60035163D1 (de) Abc1 polypeptide und verfahren und reagenzien zur modulation des cholesterolgehalts
DE60309647D1 (de) System und Verfahren zur gesicherten Behandlung von Kontrollinformationen
ATE504208T1 (de) Dekontaminationslösungen und deren verwendung zur denaturierung, modifikation, degradation, solubilisierung und entfernung von proteinen, nukleinsäuremolekülen und mikroorganismen
ATE321887T1 (de) Verfahren zur identifizierung von modulatoren des cholesterinrückwärtstransportes
DE60332382D1 (de) Zentrifugalvorrichtung und verfahren zur durchführung von bindungsversuchen
WO2004101764A3 (en) Methods of modulating metastasis and skeletal related events resulting from metastases
ATE295888T1 (de) Genfallen-konstrukt zur identifizierung und isolierung von genen
DE602004030041D1 (de) Verfahren und zusammensetzungen zur identifikation von rna-bindenden proteinen
ATE497517T1 (de) Verfahren zur trennung von polyester von anderen materialien
ATE301192T1 (de) Verwendung von neuronalem apoptose- inhibitorprotein
DE69835813D1 (de) Verfahren zur kultivierung von zellen und zur vermehrung von viren
DK1082415T3 (da) Anvendelige fremgangsmåder til modulation af angioge-nese ved anvendelse af tyrosin kinase SRC
DE69938774D1 (de) Verfahren zur isolierung, amplifizierung und charakterisierung von dns
DE60136022D1 (de) Mittel und Verfahren zur Expression von homologen und heterologen Proteinen in Rhodococcus
EP1268842A4 (de) Verbessertes verfahren für reverses n-hybrid-screening
ATE307895T1 (de) Verfahren zur identifizierung von listeria- monozytogenen und kulturmedium
DK1007649T3 (da) Fremgangsmåder til screening for interaktioner mellem transkriptionsfaktor og coaktivator

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1358354

Country of ref document: EP

REN Ceased due to non-payment of the annual fee